The drug and health products inspections database
Learn about the Drug and Health Product Inspection Database (DHPID) and the information it contains.
On this page
The DHPID gives you easy access to information about:
- Drug good manufacturing practices (GMP) inspections and licences
- Clinical trial inspections
- Medical device inspections
- Good pharmacovigilance practices (GVP) inspections
- Cells, Tissues and Organs (CTO) inspections and registrations
- Blood inspections, registrations and licences
- Donor semen inspections
Why it was created
The DHPID was created to make information on inspections and establishment licences available to Canadians. The DHPID is updated regularly and covers inspections conducted since 2012.
The DHPID also replaced the drug establishment licence live listing.
The DHPID supports Health Canada's policy on open government and regulatory transparency.
Why you might be interested
You may be interested in the DHPID if you:
- Want to know what establishments are licensed or registered in Canada for health products
- Want to access information on inspections for the different inspection programs
The main features of the DHPID include that it:
- Is designed to include up to date information
- Is easy to find and use
- Provides user friendly interface
Benefits of the DHPID include that it:
- Is a single search platform for each program
- Is mobile and user friendly
- Provides easy access in a central location to inspection information
The DHPID is designed as a virtual warehouse. It contains information on inspections, and establishment registrations and licences for health products. It also provides detailed and understandable information on these establishments. For more information on the terms used, please see the appropriate program page, as linked under the Guides and Help section on the DHPID home page.
The following is a list of terms that are used throughout:
For domestic buildings: a list of activities and categories of products for which the building is licensed or registered.
For foreign buildings: a list of activities and categories of products for which the building has been inspected.
For domestic buildings: a list of categories of products for which the building is licensed or registered.
For foreign buildings: a list of categories of products for which the building has been inspected.
- Control number
The reference number assigned to the clinical trial application (CTA).
- Currently licensed
Indicates if the inspected building currently holds a valid establishment licence, if applicable.
- Currently registered
Indicates if the inspected building currently holds a valid establishment registration, if applicable.
A high level summary of the deficiency(ies) noted during the inspection.
- Drug name
The drug for human use that was tested in the clinical trial that was inspected.
- Establishment name
The establishment name of the inspected building.
- Initial inspection deficiencies (IID)
A report providing a preliminary overview of the inspection findings.
- Inspection end date
The last date of the inspection.
- Inspection outcome
The result of the inspection, including the compliance rating and the applicable regulations.
- Inspection report cards summary
A report providing a plain language summary of the inspection.
- Inspection start date
The first date of the inspection
- Licence number
The number of the licence.
The location of the building, Canada or Other (foreign).
- Measures taken by Health Canada
The initial measures taken by Health Canada following the inspection.
- Observation number
The numbered order in which the deficiency/observation is listed.
For domestic buildings, the province of the building.
The compliance rating issued for the inspection.
- Reference number
The reference number assigned to the establishment.
For Clinical Trials, the region of the trial.
- Registration number
The registration number assigned to the inspected building.
The regulatory provision or range of regulatory provisions under which a deficiency is cited.
The alphanumeric identifier used to distinguish different buildings with the same Establishment Name.
An individual, corporate body, institution or organization that conducts a drug clinical trial.
- Summary of observation
A plain language summary of the observation(s) cited in the inspection.
- Terms and Conditions
A list of any terms and conditions on the licence, if applicable.
- Trial Phase
The phase of a clinical trial that was inspected (1, 2, 3, or 4).
- Type of inspection/Inspection type
The type of inspection conducted, e.g. initial, regular, foreign etc.
Report a problem or mistake on this page
- Date modified: